Fig. 6From: CD13 facilitates immune cell migration and aggravates acute injury but promotes chronic post-stroke recoveryUpregulation of CXCL12/CXCR4 signaling after stroke. A Percentage area CXCL12 in human subjects, n = 8. B Gating strategy for CXCL12 on live cells. C MFI CXCL12. D percentage CXCL12 on live cells. E Ipsilateral and contralateral percentage of CD31+ ECs in the wild type and CD13KO mice at day 7 post-MCAO. F Percentage of CD31+CXCR4+ cells. G MFI quantification of CXCR4 on CD31+ECs. Data presented as mean ± SEM. Data were analyzed using the unpaired t-test with Welch’s correction. Three-group data were analyzed by ordinary one-way ANOVA with Tukey’s multiple comparisons test. n = 5–7/gp. (*p < 0.05, **p < 0.01)Back to article page